NCT06366386View on ClinicalTrials.gov

Integrating Hypertension Management in DSD for HIV

Not yet recruitingOBSERVATIONAL

Enrollment

1,100

Participants

Timeline

Start Date

June 15, 2024

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2026

Conditions

HypertensionHIV

Interventions

BEHAVIORAL

Screening and treatment of hypertension among PLHIV in DSD models for HIV

In all DSD models of HIV, participants will receive screening for HTN (BP measurement), treatment of hypertension using a simplified protocol of amlodipine, hydrochlorothiazide and Losartan in a stepwise manner and laboratory monitoring for HTN medication adverse events.

Trial Locations (1)

+256

Infectious Diseases Research Collaborations (IDRCUganda), Kampala

All Listed Sponsors

lead

Infectious Diseases Research Collaboration, Uganda

OTHER

NCT06366386 - Integrating Hypertension Management in DSD for HIV | Biotech Hunter | Biotech Hunter